Info
Insider Ownership

Insider Trading & Ownership of Christopher James Frankenfield

Location: Waltham, MA
Summary: The estimated net worth of Christopher James Frankenfield is at least $73,107 dollars as of 05 Jan 2026. Christopher James Frankenfield is the Chief Financial Officer of Xilio Therapeutics, Inc. and owns shares of Xilio Therapeutics, Inc. (XLO) stock worth about $73.1K.
Signature: /s/ Kevin Brennan, Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when Christopher James Frankenfield files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Christopher James Frankenfield

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
XLO	Xilio Therapeutics, Inc.	Chief Financial Officer	$73,107	-$4,522	-5.8%	31 Dec 2025

Insider Transactions Reported by Christopher James Frankenfield:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.